Although Valeant Pharmaceuticals promised hospital discounts for its heart drugs three months ago, clinics around the country have yet to see it come to fruition.
The proposed discounts are also practically “nonexistent,” according to one of the companies, Premier, that negotiates discounts on behalf of hospitals. According to the Times, only two of Premier’s 2,500 member hospitals qualified for the 30% discount, while most will collect a price cut of a penny.
Read Full Article »